September 27, 2016 3:34 PM ET


Company Overview of UPM Pharmaceuticals, Inc.

Company Overview

UPM Pharmaceuticals, Inc. provides drug development and contract manufacturing services to pharmaceutical and biotechnology industries. Its services include formulation evaluation, such as content uniformity evaluation, dissolution testing, stability assessment, in-vitro bioequivalence determination, powder flow determination, compressibility evaluation, disintegration testing, friability testing, and tap density testing; analytical services, including dissolution testing, stability testing, purity testing, impurity identification, particle size determination, compatibility testing, solubility screening, hygroscopicity studies, methods qualification and validation, protein and peptide based ...

501 5th Street

Bristol, TN 37620

United States

Founded in 1997



Key Executives for UPM Pharmaceuticals, Inc.

Chairman of the Board and Chief Executive Officer
Age: 63
President and Chief Operating Officer
Age: 61
Executive Director of Technical Services
Vice President of Human Resources and General Counsel
Vice President of Contracting & Drug Development Services
Compensation as of Fiscal Year 2016.

UPM Pharmaceuticals, Inc. Key Developments

UPM Pharmaceuticals Opens Solids Formulation R&D Facility

UPM Pharmaceuticals announced the opening of its newly designed and qualified Solids Formulation R&D Facility. The facility is comprised of 4,000 square ft with capabilities for a wide range of pharmaceutical formulation development, including four processing suites fitted with down flow booths, a wash room, dedicated feasibility materials storage, humidity controlled capsule shell storage, and an in process testing room. The facility contains dedicated R&D equipment and scalable to clinical processing, including wet and dry granulation, particle size reduction, encapsulation, multi-layer tableting, granules, coating, hot melt extrusion and liquid fill into hard shell capsules. Batches can be processed with as little as a few hundred grams of powder allowing clients to evaluate a broad range of processes before selecting one to scale up. Additionally this saves API that is often expensive or in limited supply.

UPM Pharmaceuticals to Manufacture Sprout Pharmaceuticals' Flibanserin Tablets

UPM Pharmaceuticals has reached an agreement with Sprout Pharmaceuticals to manufacture Flibanserin 100 mg tablets. Sprout has submitted an NDA intending for Flibanserin to be the first drug approved to treat hypoactive sexual desire disorder (HSDD), the most common form of female sexual dysfunction. The tablets will be manufactured at UPM's 475,000 square-foot manufacturing facility in Bristol, Tennessee.

UPM Pharmaceuticals Reaches Agreement with BioPharmX, Inc. to Commercially Manufacture Solid Dose Iodine Supplement Tablets for Consumer Products Sector

UPM Pharmaceuticals reached an agreement with BioPharmX, Inc. to commercially manufacture solid dose iodine supplement tablets for the consumer products sector. The tablets will be manufactured at UPM's 475,000 square-foot manufacturing facility in Bristol, Tennessee, under a commercial supply agreement. Terms of the agreement were not disclosed.

Similar Private Companies By Industry

Company Name Region
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States
7 Oaks Pharmaceutical Corp. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact UPM Pharmaceuticals, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at